Thomas Engellenner

Thomas Engellenner

Pepper Hamilton LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Do-Gooders Won’t Take “No” For An Answer

About a month ago we posted an article on the dismissal of Consumer Watchdog’s appeal at the Court of Appeals for the Federal Circuit following a loss at the USPTO in an inter partes reexamination. Consumer Watchdog, Inc. had...more

12/3/2014 - Appeals Consumer Watchdog FOIA Inter Partes Review Proceedings Patents Petition for Writ of Certiorari Petitions for Review SCOTUS Stem cells USPTO WARF

Stanford Patent Found Invalid in IPR proceedings but Licensee’s IP Survives

In a decision this month (IPR2013-00308), the Patent Trial and Appeal Board (PTAB) has ruled against Stanford University’s patented method for detecting Down’s syndrome and other chromosomal defects, finding all of the...more

12/2/2014 - Inter Partes Review Proceedings Patent Infringement Patent Trial and Appeal Board Patents Popular Stanford University Validity

Do-Gooders Need Not Apply

According to its mission statement, Consumer Watchdog is a non-profit entity “dedicated to providing an effective voice for taxpayers and consumers in an era when special interests dominate public discourse, government and...more

10/22/2014 - Appeals Consumer Watchdog Covered Business Method Patents Inter Partes Review Proceedings Non-Profits Patents Post-Grant Review Standing USPTO

First Post Grant Review Petition Filed

After nearly a dozen false starts, it appears that the first genuine “Post Grant Review” (PGR) petition may have been filed with the Patent Trial and Appeal Board (PTAB) under the America Invents Act (AIA)....more

8/20/2014 - America Invents Act Patent Trial and Appeal Board Patents Post-Grant Review

Myriad - One Year Later

The Supreme Court decision last year on June 13, 2013 in Association of Molecular Pathology v. Myriad Genetics may have been a watershed moment for the biotechnology industry. So far the effects have been hard to detect, but...more

6/23/2014 - Ambry Biotechnology DNA Genetic Materials Myriad v Ambry Patent-Eligible Subject Matter Patents Roslin SCOTUS Section 101 Stem cells USPTO

The Curious Case Of Human Gene Patents

The U.S. Supreme Court heard oral arguments last month in the matter of Association for Molecular Pathology v. Myriad Genetics, a curious case that does not bode well for America’s biotechnology industry and could overturn 30...more

5/22/2013 - ACLU AMP v Myriad DNA Free Trade Agreement Human Genes Myriad Oral Argument Patents SCOTUS USPTO

Top Ten Reasons To File Your Patent Applications Before March 16, 2013

The recently enacted America Invents Act (AIA) introduces major changes to the U.S. patent laws, with some significant provisions taking effect on March 16, 2013. These provisions provide several compelling reasons to file...more

2/4/2013 - America Invents Act Filing Deadlines First-to-File First-to-Invent Patent Applications Patent Reform Patents Post-Grant Review Prior Art Prior User

7 Results
|
View per page
Page: of 1